Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 23:14:566876.
doi: 10.3389/fnins.2020.566876. eCollection 2020.

Network Diffusion Modeling Explains Longitudinal Tau PET Data

Affiliations

Network Diffusion Modeling Explains Longitudinal Tau PET Data

Amelie Schäfer et al. Front Neurosci. .

Abstract

Alzheimer's disease is associated with the cerebral accumulation of neurofibrillary tangles of hyperphosphorylated tau protein. The progressive occurrence of tau aggregates in different brain regions is closely related to neurodegeneration and cognitive impairment. However, our current understanding of tau propagation relies almost exclusively on postmortem histopathology, and the precise propagation dynamics of misfolded tau in the living brain remain poorly understood. Here we combine longitudinal positron emission tomography and dynamic network modeling to test the hypothesis that misfolded tau propagates preferably along neuronal connections. We follow 46 subjects for three or four annual positron emission tomography scans and compare their pathological tau profiles against brain network models of intracellular and extracellular spreading. For each subject, we identify a personalized set of model parameters that characterizes the individual progression of pathological tau. Across all subjects, the mean protein production rate was 0.21 ± 0.15 and the intracellular diffusion coefficient was 0.34 ± 0.43. Our network diffusion model can serve as a tool to detect non-clinical symptoms at an earlier stage and make informed predictions about the timeline of neurodegeneration on an individual personalized basis.

Keywords: Alzheimer's disease; Neuroimaging; model calibration; network diffusion model; tau PET.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Image data analysis. Workflow for region of interest (ROI) based positron emission tomography (PET) image analysis. For each subject, at each time point, we co-register the PET images to the T1 weighted magnetic resonance images (MRI), which we segment using FreeSurfer to calculate the standardized uptake value ratios (SUVR) for each region of interest (ROI). Our study contains 46 subjects, 3–4 time points, and 83 regions of interest.
Figure 2
Figure 2
Brain network models. Connectivity-weighted network from the human brain connectome and adjacency matrices of connectivity-weighted intracellular spreading model and distance-weighted extracellular spreading model. The intracellular spreading model features a small number of strong connections within each hemisphere and only few connections between them; the extracellular spreading model features a large number of moderately strong connections across the entire brain. Colors represent the connectivity between two brain regions.
Figure 3
Figure 3
Regional tau PET concentration. Mean tau concentration from PET scans across all 46 subjects with 3–4 annual scans across all brain regions. Red regions consistently exhibit high tau loads in all subjects while blue regions tend to be free of tau in most subjects.
Figure 4
Figure 4
Longitudinal tau PET concentration. Standardized uptake value ratios from PET scans for 46 subjects with 3–4 annual scans in 66 cortical regions and the hippocampus. Regions on the vertical axis are sorted by mean tau load, from top to bottom. Subjects on the horizontal axis are sorted by mean tau load across all regions and visits, from left to right. Each block of columns represents data for one subject. Within each block, each subcolumn represents data from one annual PET scan.
Figure 5
Figure 5
Parameter identification. Personalized production rate α and diffusion coefficient κ for the intracellular and extracellular diffusion models, only including the 21 subjects with a positive production rate. For the connectivity-weighted intracellular spreading model, α = 0.21 ± 0.15 and κ = 0.34 ± 0.43. For the distance-weighted extracellular spreading model, α = 0.20 ± 0.14 and κ = 0.01 ± 0.01.
Figure 6
Figure 6
Model performance. Simulated concentration csim and PET-based concentration cpet of pathogenic tau protein for intracellular and extracellular network diffusion models and null models without production, without diffusion, and without both. Each data point represents the simulated and PET-based concentration for one subject, one visit, and one region of interest. The further a data point is away from the gray line, the worse the prediction. The global residual error err of each model measures the overall prediction error of each model. (*) indicates a subject-wise error significantly higher than for the full model in paired-sample t-test. The correlation coefficient R measures the correlation strength between prediction and observation for each model. (**) indicates a correlation coefficient significantly lower than for the full model using Fisher's R-to-z transform.
Figure 7
Figure 7
Model performance. Inherent data correlation. Baseline and final PET-based concentrations cpet, and simulated concentration csim over PET-based concentration cpet of pathogenic tau protein for intracellular and extracellular network diffusion models. Each data point represents the PET-based concentration for one subject, one region of interest, and one visit. (**) Correlation coefficient R is significantly lower than for the two proposed models.
Figure 8
Figure 8
Personalized model prediction. Regional tau concentrations from raw and scaled standardized uptake value ratios craw and cpet vs. simulated tau concentrations csim with a connectivity-weighted intracellular and a distance-weighted extracellular model for personalized initial conditions, production rates, and diffusion coefficients of subject #12 from Figures 9, 10. Lateral view, left hemisphere.
Figure 9
Figure 9
Personalized model prediction. Regional tau concentrations from raw and scaled standardized uptake value ratios craw and cpet vs. simulated tau concentrations csim with a connectivity-weighted intracellular and a distance-weighted extracellular model for personalized initial conditions, production rates, and diffusion coefficients of subject #12 from Figures 9, 10. Medial view, right hemisphere.
Figure 10
Figure 10
Model prediction of intracellular model. Simulated tau concentrations csim with connectivity-weighted intracellular model for 21 subjects for 15 years in 66 cortical regions and the hippocampus. Each block of columns represents the simulation for one subject with their personalized initial conditions, production rate α, and diffusion coefficient κ. Within each block, each subcolumn represents simulated concentrations for 1 year.
Figure 11
Figure 11
Model prediction of extracellular model. Simulated tau concentrations csim with connectivity-weighted intracellular model for 21 subjects for 15 years in 66 cortical regions and the hippocampus. Each block of columns represents the simulation for one subject with their personalized initial conditions, production rate α, and diffusion coefficient κ. Within each block, each subcolumn represents simulated concentrations for 1 year.

Similar articles

Cited by

References

    1. ADNI (2020). Alzheimer's Disease Neuroimaging Initiative. Available online at: http://adni.loni.usc.edu (accessed July 31, 2020).
    1. Baker S. L., Lockhart S. N., Price J. C., He M., Huesman R. H., Schonhaut D., et al. . (2017). Reference tissue-based kinetic evaluation of 18F-AV-1451 for tau imaging. J. Nuclear Med. 58, 332–338. 10.2967/jnumed.116.175273 - DOI - PMC - PubMed
    1. Bateman R. J., Xiong C., Benzinger T. L., Fagan A. M., Goate A., Fox N. C., et al. . (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795–804. 10.1056/NEJMoa1202753 - DOI - PMC - PubMed
    1. Bejanin A., Schonhaut D. R., La Joie R., Kramer J. H., Baker S. L., Sosa N., et al. . (2017). Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain 140, 3286–3300. 10.1093/brain/awx243 - DOI - PMC - PubMed
    1. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389–404. 10.1007/s00401-006-0127-z - DOI - PMC - PubMed

LinkOut - more resources